BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17016607)

  • 1. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
    Hada S; Sato H; Virgona N; Hagiwara H; Saito T; Suzuki K; Asano R; Yano T
    Oncol Rep; 2006 Nov; 16(5):1149-54. PubMed ID: 17016607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
    Sato H; Fukumoto K; Hada S; Hagiwara H; Fujimoto E; Negishi E; Ueno K; Yano T
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):449-57. PubMed ID: 17569045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
    Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Virgona N; Hagiwara K; Yamasaki H; Negishi E; Ueno K; Yano T
    Oncol Rep; 2006 May; 15(5):1359-65. PubMed ID: 16596211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta.
    Jiang Y; Cui L; Yie TA; Rom WN; Cheng H; Tchou-Wong KM
    Oncogene; 2001 Apr; 20(18):2254-63. PubMed ID: 11402320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
    Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
    Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
    Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
    Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549.
    Zheng Q; Qin H; Zhang H; Li J; Hou L; Wang H; Zhang X; Zhang S; Feng L; Liang Y; Han H; Yi D
    Oncol Rep; 2007 Apr; 17(4):847-52. PubMed ID: 17342326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
    Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exogenous expression of SOCS box-deficient mutant ASB-8 suppresses the growth of lung adenocarcinoma SPC-A1 cells].
    Liu YZ; Li JJ; Zhang FR; Shen Y; Yao M; Wan DF; Gu JR
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jun; 35(6):548-53. PubMed ID: 12796816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells.
    Lin CC; Lee CW; Chu TH; Cheng CY; Luo SF; Hsiao LD; Yang CM
    J Cell Physiol; 2007 Jun; 211(3):771-80. PubMed ID: 17299794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X; Zhang J; Wang L; Wei H; Tian Z
    BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
    Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.